Pharma Talks

In Part 2 of this Pharma Talks conversation, Nataliya Andreychuk and Richard Schwartz continue their discussion about why experience is medicine — and explore what technology, data, and AI could mean for the future of healthcare experiences. From rethinking brand websites and using AI to understand the questions patients are really asking, to challenging pharma's approach to HCP engagement, patien...

What happens between a pharmaceutical product and the patient who needs it? In Part 1 of this Pharma Talks conversation, Nataliya Andreychuk sits down with Richard Schwartz, a healthcare and pharmaceutical industry expert with three decades of experience across pharma, consulting, agencies, publishing and technology, to explore one of the industry's biggest blind spots: the experience surrounding...

In this solo episode of Pharma Talks, Nataliya Andreychuk takes an unfiltered look at one of the biggest challenges emerging from AI adoption in the pharmaceutical industry: the velocity trap. Pharma is investing billions in artificial intelligence, accelerating content production, expanding into new channels, and making localization easier than ever. Yet at the same time, huge volumes of approved...

Steve Swan returns to Pharma Talks for a conversation about what has changed in pharma talent and recruitment since his last conversation with Nataliya Andreychuk a year ago. And the answer is: a lot. AI is now writing job descriptions, tailoring resumes, screening candidates — and, in some cases, essentially creating an AI-versus-AI recruitment loop. The result? Hundreds of polished applications,...

Part 2 of this Pharma Talks conversation with Elaine Gamble moves from identifying the challenges of Commercial and Medical collaboration to the practical steps organizations can take to create connected customer experiences. The discussion explores how AI, next best action, customer data, and organizational culture can help pharma teams work as one — without compromising compliance or scientific...

Elaine Gamble, customer engagement leader, omnichannel strategist, and former executive at Merck, Novartis, Otsuka, and other leading pharmaceutical companies, joins Nataliya Andreychuk on Pharma Talks to explore why stronger collaboration between Commercial and Medical has become essential for delivering connected, compliant, and customer-centric engagement. In Part 1, Elaine explains why silos s...

Part 2 of this Pharma Talks conversation with Matteo Colonna picks up where strategy meets execution — moving from the "why" of omnichannel and AI to the practical realities of making it work inside pharma organizations. 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk 🔗 Follow &am...

Matteo Colonna, an omnichannel transformation practitioner with a background in theoretical physics from Sapienza University in Rome and experience across consulting, digital agencies, and two major pharma companies, joins Nataliya Andreychuk on Pharma Talks to unpack why omnichannel and AI have moved from "nice to have" to business necessity. Key takeaways: Customer behavior and expectations have...

Karol Wolak, Director and Global Omnichannel Excellence Lead at Merck, joins Nataliya Andreychuk on Pharma Talks to tackle a question on everyone's mind: is AI coming for pharma jobs? His perspective is grounded in hands-on work across customer engagement and digital transformation at one of the industry's largest organizations. Views shared are Karol Wolak's own and do not represent an official p...

Agentic AI has moved pharma from answering questions to autonomously orchestrating entire workflows — but most organisations are still building the foundations it needs to run well. In this episode, Nataliya Andreychuk talks with Michal Dojlidko about what agentic AI actually requires in practice: the right data, the right guardrails, continuous upskilling, and a clear-eyed view of where humans st...

Michael Kirzhner, Omnichannel Platforms and Capabilities Leader at AbbVie, joins Nataliya Andreychuk to discuss the real state of omnichannel in pharma — what the industry has built, what's still missing, and where the next evolution lies. Michael has spent over a decade navigating the shift from field-centric models to digital-first orchestration inside one of the world's largest pharma companies...

In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Jennifer Cleall, Global Head of Digital Transformation at Ferring Pharmaceuticals, on what it actually takes to align medical and commercial teams — and where AI fits into that picture. Jennifer brings cross-industry perspective spanning pharma, med tech, and enterprise technology. Ke...

In this episode Laragh De Bhulbh shares her expertise on breaking down silos within pharma organizations, fostering cross-functional collaboration, and implementing strategic frameworks to enhance medical affairs. Discover practical tips for leaders and the importance of trust, communication, and strategic alignment in driving patient impact. Key topics: - Cross-functional collaboration challenges...

In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era. Michael built content and delivery organizations of over 1,000...

In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Lauren Leahy, who leads global and international medical capabilities operations, on what AI really means for the people working inside pharma today. Lauren brings a medical affairs perspective to a conversation that's usually dominated by commercial voices. Key takeaways: AI isn't el...

In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground. Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space. K...

Watch the first part of the conversation: https://youtu.be/PtR62juQ4FY This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation. 👥 Guests in this episode: Bruno Senouci - co-CEO at DRCOM Gwenael Meneux - co-CEO at...

Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQ This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation. 👥 Guests in this episode: Bruno Senouci - co-CEO at DRCOM Gwenael Meneux - co-CEO a...

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead. Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And th...

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice. Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day. Key takeawa...

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.lin...

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that. With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and...

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools. Key takeaways: - AI in pharma marketing requires systemic thinking, not point solutions - Content with...

Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means at the behaviour level. Key Topics: The g...

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guests in this episode: Rohit Khuttan — Practice Director, Everest Group On AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise minds...